120 related articles for article (PubMed ID: 38179738)
1. Cellular Senescence in Non-Small Cell Lung Cancer.
Zhu H; Sun J; Zhang C; Li P; Tan C; Yang M; Zhao G
Front Biosci (Landmark Ed); 2023 Dec; 28(12):357. PubMed ID: 38179738
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions.
Jha SK; De Rubis G; Devkota SR; Zhang Y; Adhikari R; Jha LA; Bhattacharya K; Mehndiratta S; Gupta G; Singh SK; Panth N; Dua K; Hansbro PM; Paudel KR
Ageing Res Rev; 2024 Jun; 97():102315. PubMed ID: 38679394
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
Peng S; Sen B; Mazumdar T; Byers LA; Diao L; Wang J; Tong P; Giri U; Heymach JV; Kadara HN; Johnson FM
Oncotarget; 2016 Jan; 7(1):565-79. PubMed ID: 26623721
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer.
Burns TF; Dobromilskaya I; Murphy SC; Gajula RP; Thiyagarajan S; Chatley SN; Aziz K; Cho YJ; Tran PT; Rudin CM
Mol Cancer Res; 2013 Apr; 11(4):329-38. PubMed ID: 23364532
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer.
Ge H; Ni S; Wang X; Xu N; Liu Y; Wang X; Wang L; Song D; Song Y; Bai C
PLoS One; 2012; 7(12):e51821. PubMed ID: 23272171
[TBL] [Abstract][Full Text] [Related]
6. Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
Adams MN; Burgess JT; He Y; Gately K; Snell C; Zhang SD; Hooper JD; Richard DJ; O'Byrne KJ
J Thorac Oncol; 2017 Jul; 12(7):1071-1084. PubMed ID: 28487093
[TBL] [Abstract][Full Text] [Related]
7. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence.
Salim H; Akbar NS; Zong D; Vaculova AH; Lewensohn R; Moshfegh A; Viktorsson K; Zhivotovsky B
Br J Cancer; 2012 Oct; 107(8):1361-73. PubMed ID: 22929890
[TBL] [Abstract][Full Text] [Related]
8. Immune senescence in non-small cell lung cancer management: therapeutic relevance, biomarkers, and mitigating approaches.
Alexa-Stratulat T; Pavel-Tanasa M; Cianga VA; Antoniu S
Expert Rev Anticancer Ther; 2022 Nov; 22(11):1197-1210. PubMed ID: 36270650
[TBL] [Abstract][Full Text] [Related]
9. Impaired Cdc20 signaling promotes senescence in normal cells and apoptosis in non-small cell lung cancer cells.
Volonte D; Sedorovitz M; Galbiati F
J Biol Chem; 2022 Oct; 298(10):102405. PubMed ID: 35988650
[TBL] [Abstract][Full Text] [Related]
10. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
13. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
14. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
15. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
Front Immunol; 2021; 12():684807. PubMed ID: 34394080
[TBL] [Abstract][Full Text] [Related]
16. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
18. IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function.
Liang J; Lu F; Li B; Liu L; Zeng G; Zhou Q; Chen L
Cell Cycle; 2019 Dec; 18(23):3300-3312. PubMed ID: 31594449
[TBL] [Abstract][Full Text] [Related]
19. The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors.
Wang D; Moothart DR; Lowy DR; Qian X
PLoS One; 2013; 8(4):e61262. PubMed ID: 23620736
[TBL] [Abstract][Full Text] [Related]
20. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
